• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

tetano

Editor, Senior Moderator
Immunity


. 2021 Mar 11;S1074-7613(21)00117-5.
doi: 10.1016/j.immuni.2021.03.005. Online ahead of print.
Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19


Peter A Szabo[SUP] 1 [/SUP], Pranay Dogra[SUP] 1 [/SUP], Joshua I Gray[SUP] 1 [/SUP], Steven B Wells[SUP] 2 [/SUP], Thomas J Connors[SUP] 3 [/SUP], Stuart P Weisberg[SUP] 4 [/SUP], Izabela Krupska[SUP] 2 [/SUP], Rei Matsumoto[SUP] 5 [/SUP], Maya M L Poon[SUP] 6 [/SUP], Emma Idzikowski[SUP] 3 [/SUP], Sinead E Morris[SUP] 4 [/SUP], Chlo? Pasin[SUP] 4 [/SUP], Andrew J Yates[SUP] 4 [/SUP], Amy Ku[SUP] 4 [/SUP], Michael Chait[SUP] 4 [/SUP], Julia Davis-Porada[SUP] 7 [/SUP], Xinzheng V Guo[SUP] 8 [/SUP], Jing Zhou[SUP] 9 [/SUP], Matthew Steinle[SUP] 9 [/SUP], Sean Mackay[SUP] 9 [/SUP], Anjali Saqi[SUP] 4 [/SUP], Matthew R Baldwin[SUP] 10 [/SUP], Peter A Sims[SUP] 11 [/SUP], Donna L Farber[SUP] 12 [/SUP]



Affiliations

Abstract

Immune response dynamics in coronavirus disease 2019 (COVID-19) and their severe manifestations have largely been studied in circulation. Here, we examined the relationship between immune processes in the respiratory tract and circulation through longitudinal phenotypic, transcriptomic, and cytokine profiling of paired airway and blood samples from patients with severe COVID-19 relative to heathy controls. In COVID-19 airways, T cells exhibited activated, tissue-resident, and protective profiles; higher T cell frequencies correlated with survival and younger age. Myeloid cells in COVID-19 airways featured hyperinflammatory signatures, and higher frequencies of these cells correlated with mortality and older age. In COVID-19 blood, aberrant CD163[SUP]+[/SUP] monocytes predominated over conventional monocytes, and were found in corresponding airway samples and in damaged alveoli. High levels of myeloid chemoattractants in airways suggest recruitment of these cells through a CCL2-CCR2 chemokine axis. Our findings provide insights into immune processes driving COVID-19 lung pathology with therapeutic implications for targeting inflammation in the respiratory tract.

Keywords: ARDS; COVID-19; chemokines; coronavirus disease 2019; cytokines; lung immunity; macrophages; monocytes; single-cell RNA sequencing; tissue resident memory T cells.
 
Back
Top Bottom